The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
A feed-forward loop amplifies nutritional regulation of PNPLA3
Open accessAbstract
The upsurge in prevalence of obesity has spawned an epidemic of nonalcoholic fatty liver disease (NAFLD). Previously, we identified a sequence variant (I148M) in patatin-like phospholipase domain-containing protein 3 (PNPLA3) that confers susceptibility to both hepatic triglyceride (TG) deposition and liver injury. To glean insights into the biological role of PNPLA3, we examined the molecular mechanisms by which nutrient status controls hepatic expression of PNPLA3. PNPLA3 mRNA levels, which were low in fasting animals, increased approximately 90-fold with carbohydrate feeding. The increase was mimicked by treatment with a liver X receptor (LXR) agonist and required the transcription factor SREBP-1c. The site of SREBP-1c binding was mapped to intron 1 of Pnpla3 using chromatin immunoprecipitation and electrophoretic mobility shift assays. SREBP-1c also promotes fatty acid synthesis by activating several genes encoding enzymes in the biosynthetic pathway. Addition of fatty acids (C16:0, C18:1, and C18:2) to the medium of cultured hepatocytes (HuH-7) increased PNPLA3 protein mass without altering mRNA levels. The posttranslational increase in PNPLA3 levels persisted after blocking TG synthesis with triascin C. Oleate (400 muM) treatment prolonged the half-life of PNPLA3 from 2.4 to 6.7 h. These findings are consistent with nutritional control of PNPLA3 being effected by a feed-forward loop; SREBP-1c promotes accumulation of PNPLA3 directly by activating Pnpla3 transcription and indirectly by inhibiting PNPLA3 degradation through the stimulation of fatty acid synthesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice, Pnpla3 is predominantly expressed in adipose tissue, where its expression level is 50–100 times higher than in the liver [50,51,52].”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [51]
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Self-citationGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Self-citationFat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
Zimmermann, R., Bogner‐Strauß, J. G., Haemmerle, G., Schoiswohl, G., Birner‐Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F., Hermetter, A., et al. (2004) · Science · doi:10.1126/science.1100747 · Cited by 2,121
Structure and function of the feed-forward loop network motif
Mangan, S., & Alon, U. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133841100 · Cited by 1,827
Repa, J. J., Liang, G., Ou, J., Bashmakov, Y. K., Lobaccaro, J. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,724
Role of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 817
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.2337/diabetes.55.01.06.db05-0982 · DOI
Cited by
Sorted by citations
Items 301–387 of 387
Paolini, E., Meroni, M., Longo, M., Badiali, S., Maggioni, M., Fracanzani, A. L., & Dongiovanni, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031601 · Cited by 4
“…by Sterol Regulatory Element Binding Protein 1c (SREBP1c)/ Liver X Receptor (LXR) and Carbohydrate-responsive-element-binding protein (ChREBP) transcription factors, which regulate lipid and glucose metabolism, respectively, suggesting that its activity is subject to nutritional control [4,8].”
Identification of NUV-244 as a PNPLA3 I148M degrading small molecule
Steigemann, P., Braeuer, N., Puetter, V., Zablowsky, N., Juenemann, K., von Nussbaum, F., Lesche, R., Dittmar, N., Schaller, D., Makowska, Z., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112384 · Cited by 4
“28 However, no PNPLA3 was detectable in western blots in different cell lines fed with oleic acid using two different antibodies against PNPLA3 (Figure S2D).”
Liu, L., Niu, Y., Guo, Z., Wang, C., Liu, H., Yang, J. H., Gao, P., & Xiang, P. (2025) · Environmental Chemistry and Ecotoxicology · doi:10.1016/j.enceco.2025.10.014 · Cited by 4
Mendez‐Garcia, C., Trini, A., Browne, V., Kochansky, C. J., Pontiggia, L., & D’mello, A. P. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0646 · Cited by 4
Kalafati, I. P., Dimitriou, M., Revenas, K., Kokkinos, A. D., Deloukas, P., & Dedoussis, G. V. (2023) · Nutrients · doi:10.3390/nu15051112 · Cited by 4
Cumulative Burden of Fatty Liver and Kidney Cancer in Young Men: A National Population-Based Study
Lee, H. Y., Han, K., & Kwon, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm14010148 · Cited by 4
Oliver, P., Caimari, A., Díaz‐Rúa, R., & Palou, A. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100434x · Cited by 4
“1c promotes adiponutrin mRNA expression in hepatocytes((13,14)), and this is similar to what happens with genes”
BackgroundIde, T. (2023) · Journal of Oleo Science · doi:10.5650/jos.ess22341 · Cited by 4
Takaki, A., Uchida, D., & Yamamoto, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00012-6 · Cited by 1
I148M PNPLA3 Variant and Progressive Liver Disease: A New Paradigm in Hepatology
Valenti, L. V. C., Alisi, A., & Nobili, V. (2011) · Hepatology · doi:10.1002/hep.25506 · Cited by 4
RetractedTrépo, E., Franchimont, D. P., & Moreno, C. (2011) · Personalized Medicine · doi:10.2217/pme.11.66 · Cited by 4
Sharma, M., Kulkarni, A. V., Kumar, P., Nori, V. B., Jagtap, N., Gupta, R., Reddy, D. N., & Rao, P. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-87449-8 · Cited by 4
Liu, Z., Zhang, Y., Graham, S., Pique-Regi, R., Dong, X. C., Chen, Y. E., Willer, C., & Liu, W. (2019) · doi:10.1101/657734 · Cited by 250
Bovee, C. E., Grandgenett, R. P., Trevino, M. B., Dutta, S. M., Peachee, S. J., Kopriva, S., Haider, F., Liu, S., Bhardwaj, G., Penniman, C. M., et al. (2025) · Endocrinology · doi:10.1210/endocr/bqaf075 · Cited by 3
Wang, Z.-N., Cai, H., Li, M., Cao, X., Lan, X., Lei, C., & Chen, H. (2015) · Gene · doi:10.1016/j.gene.2015.08.047 · Cited by 3
Zhang, H., Li, X., Chen, L., Jiang, S., Xin, Y., & Xuan, S. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.31987 · Cited by 3
“Furthermore, PNPLA3 is induced in the liver after feeding and during insulin resistance by the master regulator of lipogenesis steroid regulatory element binding protein-1c (22).”
BackgroundNAFLD e Ingesta de Fructosa en Altas concentraciones: Una Revisión de la Literatura
Carvallo, P., Carvallo, E., Barbosa‐da‐Silva, S., Mandarim‐de‐Lacerda, C. A., & del Sol, M. (2017) · International Journal of Morphology · doi:10.4067/s0717-95022017000200047 · Cited by 3
Rausch, V., & Mueller, S. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-98788-0_12 · Cited by 3
Predictive risk markers in alcoholism
Niemelä, O. J. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.05.002 · Cited by 3
Fatty Liver, NASH, and Alcoholic Liver Disease
Shimada, M., Cheng, J., & Sanyal, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04207-6 · Cited by 3
McCann, C., Viner, M. E., Donkin, S. S., & White, H. M. (2014) · Journal of Dairy Science · doi:10.3168/jds.2014-7910 · Cited by 3
“The expression of PNPLA3 mRNA in adipose and hepatic tissue is suppressed during fasting in rodents and humans, and is increased by subsequent refeeding with a high-protein or high-carbohydrate diet (Hoekstra et al., 2010; Huang et al., 2010; Oliver et al., 2012).”
BackgroundInfluentialCross talk between liver and adipose tissue: A new role for PNPLA3?
Mancina, R. M., & Spagnuolo, R. (2020) · Liver International · doi:10.1111/liv.14561 · Cited by 3
Johnson, S., Bao, H., McMahon, C., Chen, Y., Burr, S. D., Anderson, A. M., Madeyski-Bengtson, K., Lindén, D., Han, X., & Liu, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.553213 · Cited by 3
“Based on the evidence that hepatic PNPLA3 is upregulated by carbohydrate feeding(Huang et al., 2010; Kumari et al., 2012; Polson and Thompson, 2003) and functions as a PUFA-TG lipase, we sought to create a dietary context in which liver would be”
BackgroundGenetic risk of steatotic liver disease: Pathogenesis, prognosis, and implications for treatment
Kozlitina, J., Romeo, S., & Hobbs, H. H. (2026) · Hepatology · doi:10.1097/hep.0000000000001758 · Cited by 2
Self-citationZhu, G., Zhao, Q., Ran, J., Zhang, H., Yin, S., Issa, R., Shi, J., Wu, C., & Li, J. (2026) · Communications Medicine · doi:10.1038/s43856-026-01651-1 · Cited by 2
Self-citationGenetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making
Metwally, M., Eslam, M., & George, J. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0372-8 · Cited by 1
Chang, M., Cheng, J., Tai, J., Chen, W.-T., Yang, S.-S., Chiu, C.-H., Chien, R., Hsu, C., Wu, S.-J., & Fann, C. S. J. (2025) · Hepatology International · doi:10.1007/s12072-025-10906-3 · Cited by 2
“The PNPLA3 protein has a strong ability to hydrolyze triglycerides [5].”
Genetic Aspects of Non-alcoholic Fatty Liver Disease (NAFLD)
Stender, S., Grarup, N., & Hansen, T. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-98890-0_12 · Cited by 2
Science, serendipity, and the single degree
Hobbs, H. H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci124404 · Cited by 3
Self-citationGenetic Confounders of Liver Stiffness and Controlled Attenuation Parameter
Rausch, V., Mueller, J. H., & Mueller, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-40542-7_27 · Cited by 2
Can genetic influence in non‐alcoholic fatty liver disease be ignored?
Liu, Y., Day, C. P., & Anstee, Q. M. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch11 · Cited by 2
Kabbani, M., Michailidis, E., Steensels, S., Fulmer, C. G., Luna, J. M., Pen, J. L., Tardelli, M., Razooky, B. S., Ricardo-Lax, I., Zou, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.19.387613 · Cited by 2
Wagner, C., Košić, K., Bulfon, D., Breithofer, J., Jamnik, A., Zitta, C., Horvat, P., Bilweis, K., Schupp, M., Zimmermann, R., et al. (2025) · Liver International · doi:10.1111/liv.70213 · Cited by 1
“While ATGL, HSL, and PNPLA3 are expressed in hepatocytes as well as hepatic stellate cells [18, 71–73], KIAA1363 is only detectable in hepatic stellate cells [21].”
Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk
Li, H.-G., Liu, F., Zhu, H., Zhou, X., Lu, J., Chang, H., & Hu, J. (2015) · Medicine · doi:10.1097/md.0000000000002019 · Cited by 1
PNPLA3 I148M variant is the main driver of weight gain after hepatitis C cure
Pitova, V., Fraňková, S., Holinka, M., Merta, D., Vesela, S., Hubacek, J. A., Jirsa, M., & Šperl, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-11085-9 · Cited by 1
Bukhari, I. A., Ismail, M. H., Hasan, M. A., & Alzahrani, A. (2018) · Our Dermatology Online · doi:10.7241/ourd.20184.24 · Cited by 1
“A marked up-regulation of PNPLA3 in response to feeding has led investigators to alternatively propose a function for PNPLA3 in lipid remodelling rather than catabolism [60].”
BackgroundEffect of sex on the levels of galanin and adiponutrin in hypertensive patients with obesity
Herasymchuk, U. S. (2021) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2021-25(2)-17 · Cited by 1
Genetic predictors and pathophysiological features of non-alcoholic fat liver disease
Smirnova, O. V., Moskalenko, O. L., Каспаров, Э. В., & Каспарова, И. Э. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-15-78-87 · Cited by 1
The Role of Senescence in NASH-Related HCC
Chrysavgis, L., Papadopoulos, G., & Chatzigeorgiou, A. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_87 · Cited by 1
Danielsson, J. (2014) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Impact of Host Genetic Variants on Natural History and Treatment of Hepatitis C Virus Infection
Rembeck, K. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Lammert, F. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch41 · Cited by 1
Voilquin, L., Liu, T., Jung, Y., Taylor, N. P., Zhao, M., Charville, G. W., Nissen, S. B., Yki‐Järvinen, H., Altman, R. B., & Svensson, K. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.15.504026 · Cited by 1
Butcko, A. J., Kamali, P., Tiwari, N., Rahman, A. A., Teskey, G., Adeshina, K. A., Singh, N. K., Granneman, J. G., & Mottillo, E. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.24.650494 · Cited by 1
Genetic drivers of histological progression in MASLD
Romeo, S. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.11.003 · Cited by 1
Anstee, Q. M., Daly, A. K., & Day, C. P. (2013) · Wiley eBooks · doi:10.1002/9781118556153.ch14
Krawczyk, M. J. (2011) · Publications of the UdS (Saarland University) · doi:10.22028/d291-21658
Lipases and their interaction partners in Gallus gallus
Besenböck, C. (2010) · University of Vienna · doi:10.25365/thesis.10842
Susceptibility to chronic liver disease
Burza, M. A. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
2010 Faculty Bibliography of Publications
Lindsey, M., & Mason, T. (2011) · Digital Commons @ UNT Health Science Center
MOLECULAR GENETICS OF PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING 3 AND CHRONIC LIVER DISEASE
Pirazzi, C. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
C URRENT OPINION Genetic-related and carbohydrate-related factors affecting liver fat accumulation
Goran, M. I., Walker, R. W., & Allayee, H. (2012)
Stop or Click Mechanism in the Animal Kingdom.
Thilo, O. (1901) · Europe PMC (PubMed Central)
PNPLA3 Polymorphisms and Liver Aminotransferase Levels in a Mexican
Qu, H., Rento, A. R., Groe, M. L., Mirza, S., Yang, L., Hanis, C. L., Fallon, M. B., Boerwinkle, E., Fisher‐Hoch, S. P., & McCormick, J. B. (2012)
PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease
Kolesnikova, O. V., Nemtsova, V. D., & Rajendram, R. (2016) · Exposure and Health · doi:10.1007/978-94-007-7742-2_28-1
Välimäki, S. (2017) · Jyväskylä University Digital Archive (University of Jyväskylä)
Correa, M. L. M. (2017) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/25762
Pathogenesis of Nonalcoholic Fatty Liver Disease in Children and Adolescents
郑, 朝. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.103057
“186 [33],在不同种族 成人[33]及儿童[23]中均证实与 NAFLD 发病相关。研究显示该基因多态性可使脂肪营养蛋白酶活性增强, 从而促进肝脏脂肪合成[34];同时该变异也可降低肝脏细胞水解甘油三酯的能力从而导致肝脏脂肪变性”
ADIPONUTRIN LEVELS IN HYPERTENSIVE PATIENTS DEPENDING ON THE DEGREE OF OBESITY
Кравчун, П. Г., Kadykova, O. I., & Herasymchuk, U. S. (2021) · Inter Collegas · doi:10.35339/ic.8.1.10-17
“ADPN, encoded by gene the patatin-like phospholipase domain-containing 3 (PNPLA3), consists of 481 amino acids responsible for the function of the endoplasmic reticulum, the structure and function of mitochondrial membranes and lipid inclusions in hepatocytes and adipocyte membranes [9].”
BackgroundКравчун, П. Г., Kadykova, O. I., & Herasymchuk, U. S. (2021) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs06.02.077
Кравчун, П. Г., Kadykova, O. I., & Herasymchuk, U. S. (2021) · Regulatory Mechanisms in Biosystems · doi:10.15421/022149
“…is a protein encoded by the gene PNPLA3 (patatinlike domain containing 3 phospholipase), it consists of 481 amino acids responsible for endoplasmic reticulum function, structure and function of mitochondrial membranes and lipid inclusions in hepatocytes and adipocyte membranes (Huang et al., 2010).”
BackgroundGG Genotype of Pnpla3 Rs738409 Polymorphism Associated with Nash in Patients of Uzbek Nationality
(2018) · Journal of Gastroenterology & Digestive Systems · doi:10.33140/jgds/02/03/00002
PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease
Kolesnikova, O. V., Nemtsova, V. D., & Rajendram, R. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_28
Recuero, A. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-19072022-163406
Weber, S. N., & Lammert, F. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_8
Patatin-like phospholipase domain-containing protein 3 in the crossroads of hepatic fibrosis
Dutta, A. K., Chatterjee, N., & Dhar, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95696-3.00017-x
de Souza, J. G. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2023.tde-30102023-162135
Dixon, E. D., Claudel, T., White, U. A., Zimmermann, R., Haemmerle, G., Wabitsch, M., Mlitz, V., Fuchs-Steiner, C. D., Ravussin, É., & Trauner, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4585932/v1
Nádasdi, Á., & Firneisz, G. (2025) · Orvosi Hetilap · doi:10.1556/650.2025.33421
Berlanga, A., Guiu‐Jurado, E., Porras, J. A., Aragonès, G., & Auguet, T. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.03.003 · Cited by 1
Jensen, V. S., Fledelius, C., Zachodnik, C., Damgaard, J., Nygaard, H., Tornqvist, K. S., Kirk, R. K., Viuff, B. M., Wulff, E. M., Lykkesfeldt, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14052747
Xu, X. L., Deng, X., Chen, Y., Xu, W., Xu, F. L., & Liang, H. (2022) · Figshare · doi:10.6084/m9.figshare.19915447
Sharmine, S., Unger, L., Altankhuyag, A., Legøy, T. A., Ghila, L., & Chera, S. (2025) · Research Square · doi:10.21203/rs.3.rs-8013440/v1
The GATA8-GRF5-XTH9 feed-forward loop regulates cell size in poplar
Xia, Y., Wu, W., Ling, A., Jiang, S., Shu, J., Wang, S. D., Xia, X., & Kang, X. (2026) · Horticulture Research · doi:10.1093/hr/uhag019
“This regulatory mode ensures that the system can respond flexibly and accurately when faced with changes in external signals [26, 27], significantly accelerating/s-lowing down the accumulation/reduction of downstream genes [28, 29].”
Custom Sustenance Through Gut Biotics
Manna, D., Laishram, R., Das, D., & Dahuja, A. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4382-2.ch003
Zhang, Z., Su, V., Wiese, C. B., Cheng, L., Wang, D., Cui, Y., Kallapur, A. S., Kim, J., Wu, X., Tran, P. H., et al. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003601 · Cited by 1
“Analysis of public RNA-seq datasets [13] Pnpla3 is impacted by LXR activity [52], and our analysis showed that LXR motifs were differentially enriched between sexes, but have little effect on the transcriptome.”
Guillou, D. L. (2017) · theses.fr (ABES) · doi:10.70675/b26d5802z0fccz434bz8f49zaa1f25db2fa1
Identification des nouveaux déterminants génétiques prédisposant aux carcinomes hépatocellulaires
Yang, J. (2019) · theses.fr (ABES) · doi:10.70675/6f60acd0z1345z4e7aza75bzb9b14c6ced0c
Gatzios, A., Stinckens, M., Verhoeven, A., Rombaut, M., Win, D. D., Heymans, A., Loosen, A., Goethem, F. V., Kock, J. D., Rodrigues, R. M., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124587
Bu, H., Liu, L., Liu, H., Wang, H., & Wang, P. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119746
Substrate-Selective Lipolysis Facilitates Unsaturated TAG Accumulation in Obesity
Sheng, J., Qi, S., Chan, M., Wang, E., Han, X., Hsueh, W. A., Yang, L., & Wong, S. T. C. (2026) · Diabetes · doi:10.2337/db25-0526
“PNPLA3 has been reported to hydrolyze TAG PUFAs in hepatic settings independently of ATGL30, but its activity is highly tissue-specific (29).”
McMahon, R., Claudel, T., Fuchs, C., Stojaković, T., Scharnagl, H., Zimmermann, R., Haemmerle, G., Kershaw, E. E., & Trauner, M. (2026) · International Journal of Negative Results · doi:10.14302/issn.2641-9181.ijnr-25-5844
Metadata
- Authors
- Huang, Y., He, S., Li, J. Z., Seo, Y.-K., Osborne, T. F., Cohen, J. C., & Hobbs, H. H.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- University of California, Irvine (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-12
- Volume
- 107
- Issue
- 17
- Pages
- 7892-7897
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2867902
- OpenAlex
- W2096694584
- Cited by
- 386
- References
- 49
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 20 · 2023: 14 · 2022: 17 · 2021: 29 · 2020: 44 · 2019: 18 · 2018: 20 · 2017: 27 · 2016: 20 · 2015: 27 · 2014: 32 · 2013: 17 · 2012: 24
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (HL20948)
- National Heart, Lung, and Blood Institute (HL-20948, R01HL048044, HL48044, HL92550, P01HL020948, RL1HL092550)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- PNPLA3, feed-forward loop, SREBP-1c, liver X receptor, non-alcoholic fatty liver disease, obesity, fatty acid synthesis, post-translational regulation, protein stability, carbohydrate feeding, triglyceride synthesis, oleate
- MeSH terms
- Acyltransferases, Animals, Cell Line, Chromosome Mapping, Dietary Carbohydrates, Fasting, Gene Expression Regulation, Humans, Lipase, Liver, Male, Membrane Proteins, Nutritional Status, Oligonucleotides, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Chromatin Immunoprecipitation, Intracellular Signaling Peptides and Proteins, Mice, Phospholipases A2, Calcium-Independent
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review